Novo Nordisk A/S (NYSE:NVO)

51.86
Delayed Data
As of Feb 16
 +0.30 / +0.58%
Today’s Change
32.89
Today|||52-Week Range
58.37
-3.37%
Year-to-Date

Today’s Trading

Previous close51.56
Today’s open52.17
Day’s range51.71 - 52.56
Volume2,423,104
Average volume (3 months)1,657,386
Market cap$102.0B
Data as of 4:02pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)+10.80%
Earnings growth (this year)--
Earnings growth (next 5 years)+6.00%
Revenue growth (last year)+3.81%
P/E ratio20.1
Price/Sales5.48
Price/Book20.23

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co+0.95+1.22%
ABTAbbott Laboratories+0.67+1.13%
GSKGlaxoSmithKline+0.39+1.05%
BMYBristol-Myers Squibb-0.02-0.03%
Data as of 4:02pm ET, 02/16/2018

Financials

Next reporting dateMay 2, 2018
EPS forecast (this quarter)$0.69
Annual revenue (last year)$16.6B
Annual profit (last year)$5.6B
Net profit margin33.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President &
Chief Executive Officer
Lars Fruergaard Jørgensen
Executive Vice President-
International Operations
Maziar Mike Doustdar
Corporate headquarters
Bagsværd, Capital Region

Forecasts